On September 22, 2026, Supportive Care in Cancer published "Addressing sexual health after cancer: whose job is it anyway? Provider practices and communication barriers" (DOI 10.1007/s00520-026-11186-9), a qualitative study by Abby Girard, Eloise von DeWitt, G. Nic Rider, Melissa A. Geller, Rebekah Pratt, Rachel I. Vogel and Jennifer B. Reese. The researchers interviewed 21 gynecologic oncology providers — 11 gynecologic oncologists and 10 advanced practice providers such as nurse practitioners and physician assistants — across three large health systems in a single Midwestern U.S. state, in half-hour Zoom interviews conducted between May and December 2024.

Why It Matters

This is the second study in a week to land on the same conclusion from a different direction. On September 17, Griffith University published a qualitative study of 31 breast cancer survivors finding that clinicians rarely raised sexuality at all, with senior author Armin Ariana calling for sexual health to be built into standard cancer care rather than surfaced only if the patient asks first. Griffith asked patients; this study asked providers. Both found the same silence, and this one identifies the mechanism: everyone in the room believes it is someone else's job. For the sexual wellness industry, the commercial reading is uncomfortable but clear. Oncology survivorship is one of the largest addressable populations for lubricants, vaginal moisturizers, dilators and pelvic-floor devices, and the referral pathway that would put those products in front of patients is functionally broken — not because clinicians are hostile, but because the conversation is structurally orphaned. Brands that have tried to enter oncology through physician channels have been pushing on the wrong door; the APPs staffing survivorship visits are the ones already having the conversation. For anyone building clinical-workflow tools, the study also points at a specific fix: the providers who did raise the topic consistently did so when prompted by a physical finding or a routine visit structure. That is an intake-form problem and an EHR-prompt problem, not a training problem — and it is a far cheaper intervention than changing how oncologists think about scope of practice.

The finding is a delegation problem dressed up as a scheduling problem. Advanced practice providers, who typically staff post-operative, surveillance and survivorship visits, reported initiating sexual health conversations far more often than physicians — one APP estimated she raised the topic 80% of the time. Physicians, meanwhile, tended to frame sexual health as belonging to the APPs' remit. One gynecologic oncologist said the APPs "do way more of that because they see them post-op and for surveillance." The authors' argument is that this is not merely who happens to be in the room: physicians actively rationalize the handoff as appropriate scope-of-practice behavior, which converts a staffing convenience into a durable clinical norm — and leaves patients without access to extended survivorship visits with nobody raising it at all.

Timing was equally inconsistent. Most providers said sexual concerns surface after active treatment ends, when patients shift into what one clinician called "survivorship mode." During treatment, patients are focused on surviving and providers rarely raise it. When conversations do happen, they tend to be triggered by a physical finding rather than a protocol — one provider described noticing severe vaginal atrophy during an exam and using it as an opening: "now, are you having any pain or dryness that you've noticed?" The content is predictable: all participants reported dyspareunia as the most common concern raised, alongside loss of lubrication, arousal difficulty and diminished desire.

The gap this measures is between guidelines and practice, not between guidelines and nothing. NCCN has called for sexual health screening in cancer care since 2013; ASCO since 2018. Meanwhile the background prevalence is near-universal: studies find 60–100% of gynecologic cancer survivors report some form of sexual dysfunction during treatment and survivorship, with one study finding 83% of surgically treated patients reported a sexual problem and roughly half reported two or more.

Sources

Update — 2026-09-23

Initial entry — story first created.